RhumbLine Advisers
PRNB

RhumbLine Advisers’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

RhumbLine Advisers’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-43,684
Closed -$2.61M – 3064
2020
Q2 		$2.61M Buy
43,684
+19,095
+78% +$1.18M ﹤0.01% 1581
2020
Q1 		$1.46M Buy
24,589
+1,743
+8% +$102K ﹤0.01% 1712
2019
Q4 		$1.25M Buy
22,846
+8,302
+57% +$310K ﹤0.01% 1981
2019
Q3 		$411K Buy
14,544
+290
+2% +$10.6K ﹤0.01% 2415
2019
Q2 		$473K Buy
14,254
+7,542
+112% +$235K ﹤0.01% 2382
2019
Q1 		$228K Buy
+6,712
New +$213K ﹤0.01% 2692

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

RhumbLine Advisers's PRNB Position: Q3 2020 in Review

RhumbLine Advisers sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 43,684 shares — an estimated $2.61M sold.

RhumbLine Advisers first reported a position in PRNB in Q1 2019 and held it in 6 quarters. The position peaked at $2.61M in Q2 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • RhumbLine Advisers reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • RhumbLine Advisers sold 43,684 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $2.61M.
  • RhumbLine Advisers first reported a position in Principia Biopharma Inc. Common Stock in Q1 2019 and held it in 6 quarters.
  • RhumbLine Advisers's Principia Biopharma Inc. Common Stock position peaked at $2.61M in Q2 2020.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on RhumbLine Advisers's 13F filing for Q3 2020, filed 12 Nov 2020.